drugset / Trial / NCT00807209

Dose Finding Posterolateral Thoracotomy Study

NCT00807209

Phase 2 Terminated 3 enrolled Pacira Pharmaceuticals, Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

To review safety and effectiveness of two doses compared to current standard of care.

Timeline

Start
2008-12
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified Other
Subject SKY0402 Unknown 75 mg Other
Subject SKY0402 Unknown 150 mg Other
Background Bupivacaine Other / unclassified 15 mg/ml Other

Indications

No indication recorded.